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NMR spectroscopyMembrane proteins represent about a third of the gene products in most organisms, as revealed by the genome
sequencing projects. They account for up to two thirds of known drugable targets, which emphasizes their critical
pharmaceutical importance. Herewe present a study on bilitranslocase (BTL) (TCDB 2.A.65), amembrane protein
primarily involved in the transport of bilirubin fromblood to liver cells. Bilitranslocase has also been identiﬁedas a
potentialmembrane transporter for cellular uptake of several drugs and due to its implication in drug uptake, it is
extremely important to advance the knowledge about its 3D structure. However, at present, only a limited knowl-
edge is available beyond the primary structure of BTL. It has been recently conﬁrmed experimentally that one of
the four computationally predicted transmembrane segments of bilitranslocase, TM3, has a helical structure with
hydrophilic amino acid residues oriented towards one side,which is typical for transmembrane domains ofmem-
brane proteins. In this study we conﬁrmed by the use of multidimensional NMR spectroscopy that the second
transmembrane segment, TM2, also appears in a form of α-helix. The stability of this polypeptide chain was ver-
iﬁed bymolecular dynamics (MD) simulation in dipalmitoyl phosphatidyl choline (DPPC) and in sodium dodecyl
sulfate (SDS)micelles. The twoα-helices, TM2 corroborated in this study, and TM3 conﬁrmed in our previous in-
vestigation, provide reasonable building blocks of a potential transmembrane channel for transport of bilirubin
and small hydrophilic molecules, including pharmaceutically active compounds.
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Membrane proteins attract attention of scientists because of their
important and intriguing role in membrane trafﬁcking, thus being
also extensively studied drug targets [1,2]. Crossing of the membrane
for hydrophilic molecules is enabled through an ion channel or mem-
brane embedded transporter protein. Many ion-channel diseases are
associated with the selectivity and gating, which allow for organized
ionic permeation while maintaining the barrier property of the mem-
brane [3]. Discernibly, the 3D structure of a protein is mandatory for
all detailed studies of membrane transporters. There are a plethora
of approaches to resolve the protein secondary structure, including
NMR spectroscopy [4–6], X-ray crystallography and electron micros-
copy [7–9], or single molecule manipulation and detection methods,
such as atomic force microscopy (AMF) [10] and ﬂuorescence reso-
nance energy transfer (FRET) [11,12]. However, themembrane proteins
are extremely difﬁcult to prepare for experimental measurements and
only a small portion of structurally resolved proteins in the PDB data-
base (less than 5 %) are membrane proteins [13,14].
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domains of bilitranslocase (BTL), a plasma membrane protein func-
tioning as organic anion carrier. It is involved in several biological
processes in different organs; the most studied role of BTL is the
transport of bilirubin from blood to liver cells [15–20], but it was
also detected in the heart or gastrointestinal tract [21–25]. In vitro ex-
periments have conﬁrmed that BTL has an active role in the transport
of many organic molecules through the cell membrane [23,25,26]. Re-
cently it has been shown [27] that carrier-mediated and active uptake
of pharmaceutical drugs may be more common than is usually as-
sumed. We believe that BTL could be considered as a potential drug
carrier and should thus be considered in rational drug discovery and
development. For this reason alone it would be very important to re-
solve the 3D structure of BTL. The primary sequence of the 340 amino
acids long protein BTL has been available for some time [28]; howev-
er, its 3D structure is not yet solved. The comparison with other struc-
turally resolved proteins is not supportive, because BTL shows no
homology with known proteins. As the tertiary and the quaternary
structures of BTL remain unknown, the composition, arrangement,
and structure of the transporting channel is yet to be studied in detail.
However, it is assumed that the BTL polypeptide chain consists of four
membrane spanning segments, which presumably show α helical
conformation [29]. Evidence from both computational and experi-
mental studies [30–32] supports the hypothesis. The structure of
one of these helices, the third transmembrane domain (TM3) has
been previously determined experimentally in our group [33] and
supported by molecular dynamics (MD) simulations [34–38].
Antibody studies have revealed the residues 65–75 to contain
the bilirubin binding motif [19,20,29,31]. This region is located imme-
diately before the transmembrane region TM2, thus indicating the in-
volvement of TM2 in forming the transporting channel. Furthermore,
inhibition of transport by antibody raised against residues 235–246
shows the transmembrane region TM3 (220–238) to be also impor-
tant in transporting mechanism of the protein [29,31]. Therefore, a
detailed study of both transmembrane regions TM2 and TM3 were
performed considering their functional importance. The transmem-
brane region TM3 was reported previously and its helical structure
is found to be stable [33]. In the present work, we have continued
the molecular dynamic simulations and NMR studies on transmem-
brane segments TM2, TM2A and TM2B (BTL residues 73–95, 75–94,
and 73–99, respectively) to determine their structure in a membrane
like environment. In addition, CD measurements for TM2B and TM3
were also performed.2. Materials and methods
2.1. Synthetic TM2B and TM3 peptides
Synthetic peptides used in this study were purchased from
CASLO Laboratory, Denmark (www.caslo.com). The peptides TM2B
and TM3 correspond to bilitranslocase (UniProt O88750) regions
Ser73–Leu99 and Gly220–Tyr238, respectively. They were synthe-
sized as lyophilized triﬂuoroacetate salts. The synthetic sequences
of TM2B and TM3 were SSFCLFVATLQSPFSAGVSGLCKAILLKKKK
and GSVQCAGLISLPIAIEFTKKKK, respectively, with purity higher
than 93.8%. The sequences include the predicted transmembrane
regions, along with a few amino acid residues beyond the trans-
membrane region termini in case of TM2B. Due to extreme hydro-
phobicity there are four lysines (a Lys tag KKKK) added at the
C-terminus to avoid problems during synthesis, puriﬁcation and
NMR sample preparation. The four Lys tags do not replace any of
the amino acid at the C-termini of the TM2B or TM3 sequence;
they are just added to the desired AA sequence. Throughout of fur-
ther discussion we shall refer to the peptide chain Ser73 to Leu99 as
a prolonged second transmembrane segment TM2B.2.2. Transmembrane region prediction of BTL using chemometrics model
We have done the initial prediction of the transmembrane regions
of BTL using the ﬁrst version of the alpha transmembrane region
prediction model [32]. The alpha transmembrane region prediction
tool is a data-driven model based on a counter-propagation neural
network (CPNN) classiﬁer built using transmembrane and non-
transmembrane protein segments, which are characterized mathe-
matically using amino acid adjacency matrix. The developed classiﬁer
shows 90.75% of overall prediction accuracy when it is challenged
with external validation set.
The 340 residues long BTL sequence was segmented into 329
overlapping peptides, each of which was 20 amino acids long. The
CPNN classiﬁer then predicted each of the segments as either trans-
membrane or non-transmembrane. Based on this CPNN classiﬁcation,
the transmembrane regions of BTL were predicted.
2.3. Statistics based scoring function for reﬁnement of N- and C-termini
of BTL transmembrane segments
In order to improve the prediction of the transmembrane regions,
especially the transmembrane region termini, we have incorporated
statistical data in the enhanced prediction model [33]. Position specif-
ic amino acid preference was calculated for the terminal positions
of experimentally known transmembrane regions in a large non-
redundant data set derived from Protein Data Bank. The developed
amino acid preference patterns were used to score the probable
transmembrane region termini. We considered all possible terminal
residue combinations from the initial prediction made by the CPNN
classiﬁer. Each combination was then scored using the amino acid
preference data. Terminal positions with preferred amino acids
were awarded with positive scores, whereas presence of statistically
avoided amino acids was penalized. One of the top 3 scoring seg-
ments meeting a particular length and position criteria was reported
as the ﬁnal transmembrane region. As the prediction was based on
statistical data, the termini of the predicted transmembrane regions
of BTL are considered to be more statistically favorable and plausibly
closer to experimental observations.
2.4. Preparation of the predicted BTL transmembrane α-helix TM2 for the
molecular dynamic simulation
Molecular systems were constructed, simulated and analyzed
using CHARMM modeling environment [39] by analogous methodol-
ogy as used in our previous study of studying the stability of the TM3
segment [33]. The initial conformation for the amino acid sequence
that was predicted to encompass the transmembrane region TM2
(BTL residues: 73–95) SSFCLFVATLQSPFSAGVSGLCK from the initial
chemometrics prediction model (described in Section 2.2) and anoth-
er conformation of the recently developed (Section 2.3) prediction
model incorporating statistical data TM2A (BTL residues: 75–94)
FCLFVATLQSPFSAGVSGLC were generated by available CHARMM to-
pology and structural libraries [40–43]. An α-helical conformation
for each linear sequence was generated by constraining the backbone
torsion angles φ and ψ to the values of −57° and −47° for each
amino acid backbone torsion angle [44]. Analogously as in our previ-
ous study [33], additional amino acids corresponding to the residues
located prior to the start (71–72 BTL residues HL for TM2 system
and 73–74 BTL residues SS from the TM2A system) and subsequent
to (96–97 BTL residues AI for TM2 system and 95–96 BTL residues
KA from the TM2A system) the end of the transmembrane helix on
the BTL sequences were added on the C-terminal and N-terminal
end of TM2 and TM2A. These additional amino acid residues were
not constrained to the alpha helical conformation.
CHARMM-GUIMembrane builderwas utilized for the construction of
the membrane-lipid system [45]. The α-helices TM2 and TM2A were
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molecules were selected to represent the lipid bilayer [46]. A rectangular
box consisted of two layers of lipids along with 12 Å broad layers of
water molecules above and below the lipid surface. CHARMM-GUI was
also used to construct the individual parts of this complex system. Each
α-helix was inserted into the membrane using the insertion method,
where a protein is inserted into a pre-equilibrated lipid bilayer [39,45].
The ﬁnal molecular systems comprised 18,707 (TM2 system) and
16,750 atoms (TM2A system), containing 81 (TM2 system) and 72
(TM2A system) DPPC molecules respectively.
2.5. Molecular dynamics simulation procedure
Molecular dynamics (MD) calculationswere performed by CHARMM
molecular modeling suite [39]. CHARMM parameter and topology ﬁles
(version 27) for proteins and lipids were utilized to specify the force
ﬁeld parameters of the protein and lipid DPPC molecules [40–43]. Equil-
ibration of themembranewas performed using the analogous scheme as
in our previous study [33] resulting in a total of 375 ps simulation time.
The systemwas primaryminimized for 500 steps using steepest descent
(SD) method followed by 500 steps of the modiﬁed Adopted Basis
Newton–Raphson (ABNR) method.
The equilibration of the system was performed in 6 consecutive
steps with the use of several force constants (See Table S1 of the
Supporting material for the deﬁnition and description of the used
force constraints at each equilibration step). In the ﬁrst two equilibra-
tion steps (1–2) the system was simulated for 25 ps by Langevin dy-
namics using 1 fs time step. Further four equilibration steps (3–6)
were performedwith the standardMD procedure by leapfrog integra-
tion scheme. To reduce the possible problemwith the numerical inte-
gration, 1 fs time-step was used in the third step with the total
equilibration time of 25 ps. In the next stages of the integration
scheme, 2 fs step along with SHAKE algorithm was applied. The sim-
ulation times for steps 4–6 were 100 ps long [45].
Production trajectories were generated using a leapfrog integra-
tion scheme and 2 fs simulation step using SHAKE algorithm. 20 ns
long MD simulation was performed for both TM2 and TM2A trajecto-
ries. Results of the MD simulations were visualized and analyzed
using VMD [47,48] and Gnuplot program [49].
2.6. CD measurements
CD spectra were recorded for TM2 and TM3 fragments of BTL pro-
tein using Jasco J-815 spectropolarimeter at 25 °C. Experiments were
performed over the 185–260 nm range, every spectrumwas repeated
three times to increase signal-to-noise ratio. All measurements were
provided on 0.15 mg/ml peptide solutions using a 2 cm/min scan
speed. pH values of solutions were controlled just before start the
experiments and varied between 6.5 and 7.0 in aqueous solution,
with addition of 20 mM SDS, 20 mM DPC, and 20 mM DPC:SDS
micelle with molar ratio 5:1. Final spectra were corrected by
subtracting the background and analyzed as mean molar ellipticity
Θ (degree × cm2 × dmol−1) vs. wavelength λ (nm). The content of
the secondary structure was calculated from the spectra using a
CONTINLL method [50].
The analysis is based on the approximation that CD spectrum
could be presented as linear combination of secondary structure com-
ponents (Eq. (1)):
CDλ ¼∑ f kCkλð Þ ð1Þ
where fk is the fraction of each secondary structure, and Ckλ compo-
nent is the ellipticity of kth secondary structural element at each
wavelength. In the case of TM2 analysis, the Ckλ component was de-
termined from the reference database containing 37 soluble and 13
membrane proteins (SMP50) with known secondary structures.2.7. NMR spectroscopy
The NMR sample was obtained by making a solution of about
1 mM TM2B fragment in 90%/10% H2O/D2O containing about 32 mg
of deuterated sodium dodecyl sulfate micelles (SDS-d25) (Sigma Al-
drich). The SDS-d25:TM2 ratio was kept approximately as 40:1
which is exceeded the CMC (8.3 mM) at pH 6.5. An ultrasound bath
was used for nearly 20 min to increase homogeneity of the complex.
All NMR data sets were acquired at 303 K using two Agilent VNMRS
800 NMR spectrometers operated at 18.8 T (1H resonance frequency
799.81 or 799.94 MHz). Both spectrometers were equipped with four
channels, gradient unit along z-axis, DirectDrive console and 1H/13C/15N
probe-head with inverse detection. Additionally, some of NMR
experiments were performed at the same temperature on Varian
Unity + 500 NMR spectrometer (1H resonance frequency 500.61 MHz)
equippedwith three channels, z-gradient unit and 1H/13C/15N probehead
with inverse detection. 2D 1H–1H TOCSY spectra were recorded with
mixing times 15 and 80 ms using MLEV-17 pulse scheme for spinlock
[51]. In order to eliminate effect spin diffusion, 2D 1H–1H NOESY data
sets were acquired with 80, 120 and 150 ms mixing times. 13C and 15N
chemical shifts were assigned in base heteronuclear 2D 1H–15N HSQC
and 1H–13C HSQC experiments performed on natural abundance of 13C
and 15N isotopes. All chemical shifts were referenced with respect
to external sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) using
Ξ = 0.251449530 andΞ = 0.101329118 ratios for indirectly referenced
13C and 15N resonances, respectively [52]. All recorded NMR data were
processed by NMRPipe software [53] and analyzed with the Sparky pro-
gram [54].
2.8. Structure calculation of TM2 peptide
3D structure calculations were performed with CYANA 2.1 [55] soft-
ware package. The calculation protocol initialized with 200 structures
created with randomly chosen torsion angles. The 250 nontrivial (139
intraresidual, 78 sequential, and 33 medium range) 1H–1H distance
constraints were evaluated from 2D homonuclear NOESY spectrum ac-
quired with mixing times 120 ms which were applied for structure so-
lution (Table 1). The calibration of peaks volume to distance constraints
was done with the CALIBA followed with simulated annealing proce-
dure included 10,000 steps of molecular dynamic in torsion angle
space [55].
2.9. Construction of TM2 peptide in SDS micelle and molecular dynamic
simulations
The initial construction of a single molecule of SDS was done on
the basis of previously published parameters [56,57]. After minimiza-
tion in vacuum, a starting model containing 60 monomers of SDS was
placed in a cubic box enlarged by about 8 Å in each direction that in-
cluded 7126 water molecule [58]. To reach an equilibrium density of
the entire system, a 1 ns NTP MD simulation was carried out.
The simulations with the program AMBER 11 [59] were started by
positioning the TM2 fragment into the box with its center of mass co-
inciding with SDS micelle. Total charge +5 of the entire system were
neutralized using chloride ions. To remove the initial bad contact
between peptide and SDS micelle core and preventing water penetra-
tion during equilibration the peptide and bulk water were kept under
weak harmonic constraints for initial 20,000 steps of minimization
(the steepest descent method). The entire system was minimized
for 20,000 steps without any constraints. After that, the whole
complex was subjected to molecular dynamic simulations with
time-averaged (TAV) distance restraints derived from NMR spectros-
copy with the force constants for interproton connectivities equal
to 50 kcal/(mol × Å2). The geometry of all peptide bonds was
kept trans-, as follows from NMR data, with the force constant
f = 50 kcal/(mol × rad2). MD simulations were performed with a
Table 1
Statistic of distance constraints used for high-resolution 3D structure calculations and
quality ensemble of 10 NMR derived structures of TM2B peptide on the last steps of
MD simulations with TAV.
Total number of NOE restraints 250
Intraresidual (|i − j| = 0) 139
Sequential (|i − j| = 1) 78
Medium-range (|i − j| ≤ 5) 33
Long-range (|i − j| > 5) 0
Structure Z-score
1-st generation packing quality 3.97 ± 1.59
2-nd generation packing quality 3.85 ± 1.36
Ramachandran plot appearance −0.74 ± 0.48
χ1/χ2 rotamer normality −2.58 ± 0.63
RMS Z-scores
Bond lengths 1.200 ± 0.004
Bond angles 0.718 ± 0.015
Side chains planarity 0.384 ± 0.079
Improper dihedral distribution 1.077 ± 0.046
Ramachandran plot summary for residues 75…99 (%)
Backbone atoms 0.30 ± 0.08
All heavy atoms 0.45 ± 0.08
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recorded at 4 ps (2000-th step) each and 10 conformations
presented the last steps of MD simulation were chosen for ﬁnal
structure analysis.
In order to assess the inﬂuence of the parameters needed to start
the molecular dynamic simulations, a different protocol was tested.
The 80 SDS molecules together with one molecule of TM2 peptide
were positioned in the water box with a volume corresponding to
the SDS concentration in NMR experiments (170 mM). The simula-
tions with previously evaluated distance constraints (TAV protocol)
were performed for 17 ns long trajectories. The evaluated structural
data were compared with those obtained by the initially applied
protocol.
3. Results and discussion
3.1. BTL transmembrane regions predicted by the chemometrics models
The initial prediction of the transmembrane regions of BTL was
performed using the developed alpha transmembrane region predic-
tion model as described previously [32]. We considered only long
stretches of 10 or more consecutive overlapping segments predicted
as transmembrane for the ﬁnal prediction of the transmembrane re-
gions, and further analyzed them. Four such stretches of consecutive
segments were predicted as transmembrane in case of BTL that
span over residues 16–53 (19 segments), 63–103 (20 segments),
213–246 (15 segments), and 250–285 (17 segments). As the protein
segments are overlapping, instead of reporting these whole stretches
as transmembrane regions, only the central residues of these trans-
membrane segment stretches were considered. This was to make
sure that the residues in predicted transmembrane regions were
common to more segments predicted as transmembrane than as
non-transmembrane. The initial transmembrane regions of BTL,
TM1, TM2, TM3, and TM4, were accordingly predicted to be at resi-
dues 24–45, 73–95, 221–238, and 258–277, respectively [32].
In the next step, based on the initial prediction, the transmem-
brane regions were predicted utilizing statistical data on amino acid
preference. The incorporation of statistical data helps in ﬁne-tuning
the transmembrane region termini, and makes the predictions more
statistically plausible. Instead of reporting the central residues of
the predicted transmembrane stretch as the ﬁnal transmembrane re-
gion, the peptide sequences, deﬁned by all the possible combinations
of the termini of the constituent overlapping segments forming atransmembrane stretch, are considered as candidates for the trans-
membrane region. Each peptide sequence, thus formed, was then
scored using the statistically generated amino acid preference pat-
terns. The transmembrane region was predicted such that it was
bounded by best scoring combination of terminal residues. In case
of transmembrane region TM2 of BTL, the initially predicted region
73–95 had a lower statistical score than the top scoring region,
which was found to be at 75–94 (TM2A). The other three transmem-
brane regions predicted are TM1A 24–48, TM3A 220–238, and TM4A
254–276. Therefore, in both the initial and improved predictions, the
central residues of the transmembrane regions remain same with
only variation at the terminal residues. The predicted transmembrane
region is therefore essentially similar in both cases, with TM2A being
more statistically favored.
3.2. Assessment of stability of the predicted BTL transmembrane helix 2
by the MD simulation in the DPPC membrane
MD simulation was performed for BTL transmembrane helix TM2
(residues 73–95) and its variant TM2A (residues 75–94) to investi-
gate if the BTL sequences could adopt a stable helical conformation.
In order to enable a comparison with our previous study [33] the
same protocol of the data analysis was applied.
The structure of the starting transmembrane α-helices TM2 and
TM2A is shown in Fig. 1. Two additional amino acids were added on
the C-terminal and the N-terminal end of each of the α helices in
order to enable both ends of the α helix to explore more conforma-
tional space and soften the boundary. The water molecules mimicked
extracellular and intracellular compartments. Despite reasonably
long 20 ns MD simulation runs a caveat must be stated that this sim-
ulation time does not enable a full coverage of the conformational
space for an unambiguous quantitative stability assessment [33].
The produced trajectories were visually inspected for overall conforma-
tional changes and in both systems under study (TM2 and TM2A) the
α-helical conformation was retained. High resolution animations for
both TM2 and TM2A systems are provided (see Supp. Mat., Movie S1
and Movie S2).
Representative snapshots of the α-helices TM2 and TM2A from
the molecular dynamics (MD) simulation in the lipid membrane are
presented in Fig. 1. Their secondary structure was visualized using
STRIDE algorithm within VMD software suite [48]. The conformation-
al behavior in time showed comparable overall structure. Both se-
quences TM2 and TM2A displayed preserved α-helical secondary
conformation. The presence of proline in the predicted transmem-
brane sequence (Pro85) resulted in an expected kink formation in
both helices due to the sterical interference with the backbone of
the preceding turn. These observations are in line with literature
data regarding the secondary structure behavior of helices in mem-
brane environment [60,61]. Also similar effect was observed in our
previous study of TM3 where a Pro231 in the transmembrane
α-helix showed analogous behavior [33]. Thus, from the qualitative
perspective stable helix was retained for both helices within the
performed MD simulation times.
Subsequently, RMSD values for all backbone atoms initially gener-
ated in the α helical positions were calculated. The RMSD values were
calculated by aligning all conformations of the individual α helix to
the last MD-generated α-helix conformation [33]. For the structural
alignment, backbone atoms (C', CA, N) were used for those residues
that were predicted to form the α-helix by the chemometrics predic-
tions [32]. Obtained RMSD parameters corroborated that α-helix con-
formations of both TM2 and TM2A did not undergo substantial
changes during the MD simulations. The average RMSD for helix
TM2 was 0.72 Å with a standard deviation of 0.29 Å, and for the
helix TM2A the average RMSD value was 0.59 Å with the standard de-
viation of 0.21 Å. Also RMSD graphs were plotted for both simulated
systems as a function of the simulation time and are schematically
Fig. 1. (A) The predicted TM2 (left) and TM2A (right) transmembrane BTL segments inserted into the DPPC membrane and surrounded by water molecules. (B) Representative
snapshots of the α helices TM2 (left) and TM2A (right) from the MD simulation with depicted approximate borders of the α helical structures. The BTL Pro85 residue where
the α helix kink is located is highlighted in thicker line atomic model.
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tegrity during the MD simulation.
We also focused on the distribution of the torsion angles φ and ψ
for both systems during the MD simulations [62]. Three dimensional
Ramachandran plots are useful for viewing the frequency distribution
of all dihedral backbone angle values during the MD simulation. Only
speciﬁc values for torsion angles are allowed in the α-helical confor-
mation. The obtained 3D Ramachandran histograms are displayed in
the Fig. 2A for the backbone angles of those residues that were
predicted to be in the α-helix. The initial φ and ψ torsion angles of
−57° and−47° [44], used to constrain the predicted BTL protein se-
quence into the standard helical conformation remained within these
values throughout the MD simulation. The ψ dihedral angle of one
residue and the φ dihedral angle of the subsequent residue sum to
approximately−105° and the backbone φ and ψ dihedral angles typi-
cally adopt values around −60° and −45°, respectively [39,60]. In
Fig. 2A, a very uniform and stable distribution of backbone dihedral
angles was observed around values of torsion angles typical for the
α-helix. VMD program was further used to produce two dimensional
plots where the simulation time from 20 ns molecular dynamics tra-
jectory is plotted against the secondary structure analysis of each
frame of the protein structure. The overall plots for both α-helices
are presented in Fig. 2B. The secondary structure again appears to
be fully stable in both systems.The overall ﬁndings of our MD assessment are that BTL sequences
TM2 and TM2A predicted by the chemometrics approach could adopt
a stable α-helical conformation when inserted into the DPPC mem-
brane during the 20 ns MD simulation. Since the only major differ-
ence between both analyzed sequences was in their length 73–95
sequence in TM2 compared to a slightly shorter 75–94 sequence in
TM2A, these results indicate that a longer sequence 73–95 which en-
compasses the whole shorter TM2A is still fully stable.
3.3. CD measurements reveal α-helical conformation of TM2B and TM3
peptides in SDS micellar environment
In a lipid-free aqueous solution, the CD spectra exhibited only a
single negative band near 198 nm of both, TM2B and TM3 fragments
(Fig. 3). The minimum in that region could be described as the π–π*
electronic transition of the peptide bond usually observable near
200 nm [63]. Quantitative analysis of CD spectra performed with
the CDPRO program [50] reveals that in a lipid-free solution, the
TM2B and TM3 constitute predominantly of a random coil conforma-
tion and have a very low tendency of formation of α-helical struc-
tures (~8%). An addition of a detergent causes changes of CD
spectra indicating that TM peptides alter their structure upon binding
to the micelle. In particular, the CD data recorded in the micelle
environment exhibited two negative extremes observed at 208 and
Fig. 2. (A) Three dimensional Ramachandran histograms for the backbone torsion angles ϕ and ψ which were predicted to be a part of the transmembrane helix (generated for
residues: 73–95 TM2 helix and 75–94 TM2A helix), (B) Two dimensional plots of the secondary structure analysis of each frame of the protein structure against simulation time
from the MD simulation. Purple color depict the α helix structure (green indicated the turn structure and blue depicted the 310 helical structure) Residue numbers on the y-axis
are from 1–27 or 1–24 which corresponds to 73–95 or 75–94 residues of the BTL sequence.
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indicates that the helical structure content varies from 32% to 42 %
in micelle-bound TM2B which is higher than that in previously stud-
ied TM3 peptide, where the α-helical conformation does not exceed
25% in any of the studied micelle-bound state. Moreover, the level
and/or stabilization of the helical fold in the TM2B and TM3 appear
to depend on the nature of the polar head of the lipids. The CD spectra
of TM2B segment in DPC exhibited higher population of α-helicalconformation than in SDS, whereas in case of TM3 fragment, the
opposite effect is detected. The binding of peptides to a micelle is a
complex dynamic process controlled by two major non-covalent in-
teractions: electrostatic interactions between the polar head groups
on the micelle surface and the “charged” side chains of the peptide
and hydrophobic interactions between the hydrophobic side chains
of the peptide and the hydrophobic core of the micelle [64]. Thus,
the dissimilarity in helicity in TM2B and TM3 peptides in different
Fig. 3. The CD spectra of transmembrane TM2B (left) and TM3 (right) fragments from BTL protein at pH 6.5 in aqueous solution (black) and various detergents: SDS (red), DPC
(green), and mixture DPC:SDS (blue).
Fig. 4. Structure calculation of BTL TM2Bpeptide. Themapof distance contacts is shownon
the top. The ribbon presentation of TM2B structure is presented on the bottom.
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electrostatic interactions that occur between the peptide and the
polar head groups of the micelles.
3.4. Protein NMR— assignment of resonances in TM2B fragment of BTL in
SDS-d25 micelle and secondary structure
The structural analysis of proteins spanning the hydrophobic
membrane regions requires a proper selection of detergents suitable
for the NMR spectroscopy [65,66]. The initial screening performed
with the CD spectroscopy shows that in case of TM2B as well as
TM3 peptides, the SDS micelles provide an appropriate environment
for hydrophobic transmembrane segments of proteins to exhibit heli-
cal structures. It was also demonstrated that so prepared samples,
which remained stable for a long time, enable a good quality NMR
spectra (See Supp. Mat., Fig. S2). For evaluation of high-resolution
3D structure of TM2B fragment of BTL protein the similar procedure
described for TM3 peptide was applied [33]. The assignment of 1H
resonances was performed on the basis of 2D homonuclear TOCSY
spectra acquired with two (15 and 80 ms) mixing times. These data
sets were supplemented with 2D heteronuclear 1H–15N and 1H–13C
HSQC spectra recorded on natural abundance of 15N and 13C isotopes
(Supp. Mat., Fig. S2). As a result, 166 chemical shifts of 1H resonances
(completeness 87 %) were assigned. The spatial structure of TM2B
peptide was solved on the basis of 250 (139 intraresidual, 78 sequen-
tial, and 33 medium range) nontrivial 1H–1H NOE distance con-
straints yielded from analysis of 2D NOESY spectra (Table 1).
Observed NOESY distance constraints reveal existence (i, i + 3) and
(i, i + 4) contacts characteristic for α-helices in C-terminal part of
TM2B peptide (Fig. 4). Experimental data suggest that residues be-
tween Ser87 and Leu99 on C-termini exist in α-helical conformation.
The N-terminal part of TM2B fragment contains short one turn
α-helical motif formed by residues Cys76–Thr81 (Fig. 4). Our struc-
ture calculations performed on a set of 250 (139 intraresidue, 78 se-
quential, and 33 medium-range) distance constraints (Table 1) with
the CYANA program conﬁrm existence of a helix–loop–helix motif
in that region (Fig. 4).
3.5. Structural analysis of BTL TM2B peptide in SDS micelle
The 3D structure obtained in the ﬁrst stage of structure analysis
was used as a starting structure for molecular dynamic simulation
procedure with time-averaged distance restraints (TAV). The BTL
transmembrane TM2B peptide was placed in SDS micelle and water
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[59]. The protocol of creation micelle and all other parameters used
for simulations were described in detail in our previous publication
[33]. Due to a long time needed for stabilization of the position of
TM2B peptide inside the SDS micelle, the time of MD trajectory was
extended to 10 ns (Supp. Mat., Fig. S3), which is two times longer
than the TM3 peptide simulations. All experimental data used for
structure evaluation and quality analysis of solved 3D structure with
WhatIf program are presented in Table 1.
The 3D structure of BTL transmembrane TM2B peptide evaluated
after 10 ns MD simulations appears as helix–loop–helix motif
with two α-helices buried inside hydrophobic part of SDS micelle
(Fig. 5). The N- and C-terminal α-helices contain residues Cys76–
Leu82 and Phe86–Leu99, respectively. The Pro85 in loop region is in
conformation trans- and the interhelical angle between N- and
C-terminal α-helices is 80 ± 2.5° (Fig. 5). The residues Gln83–Pro85
that constitute the central loop are located on the outer part of SDS
micelle and accessible for solvent (Fig. 5). Due to expected strong in-
teractions of C-terminal Lys-Tag with the micelle surface, the MD sim-
ulations were performed with another protocol excluded ‘size effect’
of the media (described in Section 2.8). The calculations exhibited
a similar fold of TM2B fragment in SDS detergent, characterized
with exposed central loop and interhelical angle between N- and
C-terminal helices of nearly 80° (See Supp. Mat., Fig. S4).
The NMR studies revealed the transmembrane region TM2B to be
in helix–loop–helix motif. This ﬁnding is not uncommon in view of
the recent extensive study of transmembrane proline-containing pep-
tides in various lipid environments (DLPC (1,2-dilauroyl-sn-glycero-3-
phosphocholine), DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine)
and DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) lipid bilayers of
different thicknesses) using solid stateNMR [61,67]. Signiﬁcantly, regard-
less of lipid identity the segmental directions of peptide segment on ei-
ther side of the proline adopt signiﬁcant tilt angles (from 0° to 70°)
with respect to the lipid membrane normal. The effect of the missing
intra-helical NH…O = C hydrogen bond between the proline (which
has no NH group) and the amino acid four residues earlier in the
α-helical sequence causing the distortion was further enhanced by the
effect of globular micelle structure (see graphic abstract). This is coupled
to the fact that the peptide is buried in the hydrophobic SDS micelle and
the effect of the aqueous phase surrounding the micelle cannot be ruledFig. 5. High-resolution 3D structure of transmembrane TM2B fragment of BTL protein in SDS
11 program suite. The structure presents as helix–loop–helix motif with Pro85 as a centralout in a simple way. Thus, the peptide tilted shape appears to be plausi-
ble. It awaits further study before we canmake a rationale about its pos-
sible role in the BTL transmembrane functional properties.
The two helices were found at positions Cys76–Thr81 and Ser87–
Leu99, and the complete transmembrane region consisted of residues
Cys76–Leu99. Even the ﬁve residues (Lys95–Leu99) that extend be-
yond the C-terminal of the transmembrane region TM2A (Phe75–
Cys94) predicted by the model, show helical structure, which is still
in accordance with the prediction results (Fig. 6). It has to be stated
that in order to facilitate the synthesis and puriﬁcation the peptide se-
quencewas amended by addition of a Lys Tag containing four lysine res-
idues (KKKK) at the C terminal. Interestingly, the structure of this tail is
also helical (Fig. 5), however, such observation can be discarded as an
artifact of little importance for the main purpose of the present study.
As the ﬁnal transmembrane regions were predicted using statisti-
cal amino acid preference pattern, the region Phe75–Cys94 was found
to be more statistically favorable with higher scores for the N- and
C-terminal positions. However, both regions Phe75–Cys94 (from
ﬁnal prediction model) and Cys76–Leu99 (from NMR studies) came
from the transmembrane region stretch Gly65–Gln103 as predicted
by CPNN classiﬁer. As explained before (Sections 2.2, 2.3 and 3.1),
all the transmembrane regions from a single transmembrane stretch
have the same conserved core with different combinations of termi-
nal residues, and all have the equal probability to represent the actual
transmembrane fragment. Therefore, the BTL segments Phe75–Cys94
or Cys76–Leu99, sharing the same conserved core residues, have an
equal probability to form the transmembrane region.
Residues from TM2B fragment exposed to solution could be select-
ed with Radial Distribution Function (RDF) (Fig. S5) evaluated with
the ptraj program from AMBER 11 software suite on the basis of the
high-resolution 3D structure. A detail analysis of extracted data ex-
hibits Ser73, Ser74, Cys76, Ala80, Gln83, Pro85, Ala88, and Ser91 as
residues with high solubility of side chains (Fig. 6A). As follows
from the list, those residues constitute mostly N-termini and the cen-
tral loop of the helix–loop–helix motif which are more accessible to
solvent due to their location in the outer region of the SDS micelle.
In comparison with the previously determined high-resolution 3D
structure of TM3 fragment in SDS media, a stronger kink is observed
in the helix–loop–helix motif of the TM2B segment. Also the solvent
accessible surface appears to be more evenly shaped (Fig. 6B).micelle obtained after 10 ns molecular dynamic simulations using TAV with the AMBER
residue.
Fig. 6. The surface representation of 3D structures of TM2B and TM3 fragments of BTL
protein evaluated in SDS micelle. (A) 3D structure of TM2B fragment. The ﬁve residues
on C-termini extended to cytoplasm are shown as ribbon. (B) 3D structure of TM3 frag-
ment, previously determined in our group [33]. Residues exposed to the water solvent
as followed from analysis of RDF are colored in green. In case of TM2B there are Ser73,
Ser74, Cys76, Ala80, Gln83, Pro85, Ala88, and Ser91 (Supp. Mat., Fig. S5). For TM3 frag-
ment there are Cys224, Srr229, Leu230, Ile232, Glu235, and Phe236 (see Fig. 9 in [33]).
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channel we calculated hydration number of the determined 3D struc-
tures of TM2B and TM3 fragments of BTL protein (Fig. 7). In order to
compare the solvent accessible residues, both fragments were ar-
ranged in such a way that the prolines – Pro85 in TM2 and Pro231
in TM3 fragments – are settled in the central position. As follows
from the hydration number data the residues in TM2B and TM3 seg-
ments are shifted by one residue, nevertheless, a speciﬁc formation
of transmembrane helical structures inside the BTL anion channel
can be suggested.Fig. 7. The variation of the hydration number of heavy atoms of each side chain of TM2
and TM3 peptides calculated from RDF using 3D structures in SDS micelle. Please note,
according proposed model of BTL anion channel [33], the sequences are arranged in
antiparallel way deﬁned prolines in TM2B (Pro85) and TM3 (Pro231) as a central
residues.In the entire stretch Phe75–Leu99 there is only one proline resi-
due, Pro85, which causes a break in helical structure conﬁrmed by
NMR study (Leu82–Phe86 loop, Fig. 4). This observation exhibits an
additional argument that the core residues of the TM2B segment,
the Phe75–Lys95 stretch of BTL protein span the cell membrane,
since the proline kinks are often observed in α-helices of integral
membrane proteins [67–70]. Furthermore, a recent study indicates
that transmembrane helices can experience a considerable ﬂexibility
[71,72]. The authors concluded that the introduction of kinks is a
common feature in evolutionary steps, and helix distortions can be
readily accessed during conformational changes. These data indicate
that membrane protein structure could be much more ﬂexible than
is assumed in general, which might have inﬂuenced the evolution of
the membrane proteins and optimization of their structure, function
and dynamics.
4. Conclusions
In the present study we present the chemometrics model based
predictions of the bilitranslocase structure forming four transmem-
brane α-helices TM1–TM4. The proposed transmembrane regions
are corroborated by results from previously published antibody stud-
ies, where two antisequence antibodies are tested [19,20,29,31]. In
both cases, the tested antibodies are bound immediately adjacent to
the predicted transmembrane region termini and inhibit the trans-
port mechanism of the protein. Therefore, it is suggested that the
transmembrane regions TM2 and TM3, adjoining the tested antibody
binding sites, are signiﬁcantly involved in the transport channel
formation. The helical structure of the predicted segment TM2 was
studied using 20 ns molecular dynamics in the DPPC membrane
environment and it was shown to retain a structurally stable confor-
mation. CD measurements in SDS environment show α-helical con-
formation of the TM2 (TM2B) and TM3 peptide chains. The TM2B
segment with attached LysTag was studied in SDS micelle by the
use of 2D NMR spectroscopy and revealed a helix–loop–helix motif.
This ﬁnding is in line with the results of an extensive study of proline
containing peptides in membranes of various structures and thick-
ness [67] and a variety of other globular and membrane proteins
[68–70]. Similarly to previously studied TM3 [33], the TM2 segment
has a proline-induced kink at an equivalent position — in the middle
of the transmembrane region and considering the analysis of the
radial distribution function plots of the segment TM3 we can con-
clude that TM2 and TM3 may represent crucial parts of a hydrophilic
channel within the membrane. The 3D structural data of TM2B seg-
ment obtained in this study support our hypothesis about transmem-
brane domains of bilitranslocase, however, for an explanation of the
transport mechanism additional structural data about the relative po-
sitions of the TM2 and TM3 in the membrane would be required. The
spatial coupling of the TM2 helix–loop–helix motif with the helical
structure of TM3 and the possibility of the two segments to form a
channel for transport of small molecules to perform the biological
function of the transmembrane protein BTL is the subject of our sub-
sequent study.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.06.006.
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